z-logo
open-access-imgOpen Access
What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring
Author(s) -
Rodolfo J. Galindo,
Christopher G. Parkin,
Grazia Aleppo,
Anders Carlson,
Davida F. Kruger,
Carol J. Levy,
Guillermo E. Umpiérrez,
Janet B. McGill
Publication year - 2021
Publication title -
diabetes technology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.142
H-Index - 88
eISSN - 1557-8593
pISSN - 1520-9156
DOI - 10.1089/dia.2021.0107
Subject(s) - medicaid , medicine , continuous glucose monitoring , diabetes mellitus , type 2 diabetes , type 1 diabetes , intensive care medicine , health care , endocrinology , economics , economic growth
Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for CGM coverage required by the Centers for Medicare & Medicaid Services (CMS) ignore conclusive evidence that supports CGM use in various diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the CMS eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here